Donna H. Ryan, MD, Professor Emerita at Pennington Biomedical Research Center, joins the podcast to discuss obesity therapies and the results of the SELECT trial.
Highlights
TIMI turning 40 | Exciting Storylines in 2024 | A Graveyard of Weight Loss Drugs | Breakthrough of Semaglutide (Ozempic/Weygovy/Rybelsus) | SELECT Trial | Obesity as a Disease | Nick and David’s Podcast Resolutions